Primary Progressive Aphasia and Other Frontotemporal Dementias: Diagnosis and Treatment of Associated Communication Disorders is the second volume in the “Medical Speech-Language Pathology” book series. It is intended to fill an unmet need to assist clinicians, students, and related healthcare professionals in the diagnosis and treatment of the title disorders. There is a growing population of individuals diagnosed with various forms of Frontotemporal Dementia (FTD) and Primary Progressive Aphasia (PPA), and this number is likely to increase as medical practitioners and speech-language pathologists (SLPs) become more expert at identifying these conditions. More clinicians will be seeing, and treating, patients with a diagnosis of FTD or PPA. Toward that end, the goal of this book is to expand this clinical knowledge base and support the development of skills in diagnosis, but also in clinical management. Within each chapter is a concise presentation of available evidence-based practice and research findings, with a focus on sharing information that is clinically applicable and digestible for non-researchers. Each chapter provides a comprehensive outline of testing that will assist in the diagnosis of the cognitive-communication disorders associated with FTD, PPAs, and primary progressive apraxia of speech (PPAOS). Disclaimer: Please note that ancillary content (such as documents, audio, and video, etc.) may not be included as published in the original print version of this book.

Primary progressive aphasia is a type of dementia that progressively impairs language abilities (speaking, understanding, reading and writing) and may eventually affect other aspects of thinking, movement and/or personality. For the person with primary progressive aphasia, these problems have a profound effect on their ability to communicate, which in turn impacts their relationships, social networks and ability to participate in everyday activities that depend on communication. Recent understanding of primary progressive aphasia has grown enormously, however, and this book provides an up-to-date survey of research relevant to the clinical care of people with primary progressive aphasia. It covers initial diagnosis, neuropathology, genetics and typical patterns of progression from early- to late-stage disease, with a special focus on management and intervention for a range of different language symptoms and everyday communication activities. This book is suitable for a wide readership, from neurologists, geriatricians and other medical specialists, to general practitioners, speech and language therapists, occupational therapists, psychologists and students in these fields. It was originally published as a special issue of the journal Aphasiology.

New edition, completely rewritten, with new chapters on endovascular surgery and mitochrondrial and ion channel disorders.

Distils the most valuable discoveries in dementia research into clear, insightful chapters written by international experts.

Book 3 in the dementia series focuses on the second type of frontotemporal dementia (FTD): Primary Progressive Aphasia (PPA). This dementia attacks one's language skills.

This 2007 book provides a much needed review of frontotemporal dementia and related syndromes.

Now presented in full color, this updated edition of Memory Loss, Alzheimer's Disease, and Dementia is designed as a practical guide for clinicians that delivers the latest treatment approaches and research findings for dementia and related illnesses. Drs. Budson and Solomon — both key leaders in the field — cover the essentials of physical and cognitive examinations and laboratory and imaging studies, giving you the tools you need to consistently make accurate diagnoses in this rapidly growing area. Access in-depth coverage of clinically useful diagnostic tests and the latest treatment approaches. Detailed case studies facilitate the management of both common and uncommon conditions. Comprehensive coverage of hot topics such as chronic traumatic encephalopathy, in addition to new criteria on vascular dementia and vascular cognitive impairment. Includes new National Institute on Aging–Alzheimer's Association and DSM-5 criteria for Alzheimer’s Disease and Mild Cognitive Impairment. Learn how to use new diagnostic tests, such as the amyloid imaging scans florbetapir (Amyvid), flutemetamol (Vizamyl), and florbetaben (Neuraceq), which can display amyloid plaques in the living brains of patients. Updated case studies, many complete with videos illustrating common tests, clinical signs, and diagnostic features, are now incorporated into the main text as clinical vignettes for all major disorders. Brand-new chapters on how to approach the differential diagnosis and on primary progressive aphasia. Expert Consult eBook version included with purchase. This enhanced eBook experience allows you to search all of the text, figures, references, and videos from the book on a variety of devices.